August 3, 2018

Center for Aquaculture Technologies applies for fish sterility patent
 
 
In July, the Center for Aquaculture Technologies (CAT), a leading aquaculture R&D company focused on improving productivity, efficiency and sustainability in the aquaculture industry, filed a patent application regarding a method of generating sterile fish, shrimp, or mollusks. 
 
The application is the first in a planned series of patents covering tools and methods for making aquatic organisms sterile, the company said.
 
"This technology has broad applicability for aquaculture, with the ability to significantly improve productivity in grow-out while providing environmental protection for the industry,"  Dr. John Buchanan, CEO of CAT, commented.
 

"Thanks to our dedicated research team led by Dr. Xavier Lauth, we plan to soon offer this efficient technology to achieve 100% sterility in the animals in an aquaculture production system."
 

CAT operates with two laboratories: its research hub in San Diego, California, US, and the world's only Level 3 certified pathogen containment, private aquaculture wet lab located on Prince Edward Island in Canada. 
 

Thanks to the expertise of its team and the unique versatility of its labs, CAT is enabling the aquaculture industry to achieve efficient production growth without endangering the natural environment, the company stated.
 

CAT is currently in active discussions with several potential investors to further develop its current R&D portfolio, with an opportunity to capitalise on the new biotechnologies that bring changes to the growing aquaculture sector. 
 

The sole shareholder of CAT is currently Linnaeus Capital Partners B.V., based in Amsterdam, the Netherlands.
 

- The Center for Aquaculture Technologies